GeneBio Systems
Purified Anti-Human CD22 Antibody[LL2]
Purified Anti-Human CD22 Antibody[LL2]
SKU:AN007540P
Couldn't load pickup availability
Size:1mg
Storage:Store at 4°C valid for 12 months or -20°C valid for long term storage, avoid freeze / thaw cycles.
Shipping:Ice bag
Exp date:12 months
Category ID_II:Primary Antibodies
Category ID_III:Flow Cytometry Antibodies
Abbreviation:CD22
Target Synonym:Lyb;SIGLEC2FLJ;B-cell receptor CD;T-cell surface antigen Leu;sialic acid binding Ig-like lectin;Sialic acid-binding Ig-like lectin;CD22;SIGLEC-2;SIGLEC2;B-cell receptor CD22;BL-CAM;B-lymphocyte cell adhesion molecule;CD22 antigenMGC130020;CD22 molecule;Lyb-8;sialic acid binding Ig-like lectin 2;Sialic acid-binding Ig-like lectin 2;SIGLEC2FLJ22814;T-cell surface antigen Leu-14;Siglec-2;CD22 molecule;B cell receptor CD22 precursor;B lymphocyte cell adhesion molecule;BL CAM;BLCAM;CD 22;CD22 antigen;CD22 protein;Lectin 2;Leu14;Lyb8;MGC130020;sialic acid binding Ig like lectin 2;Sialic acid binding immunoglobulin like lectin 2;SIGLEC 2;T cell surface antigen Leu 14
Research Areas:Immunology;Cancer;Stem Cells
Conjugation:Unconjugated
Host:Mouse
Species reactivity:Human
Application:FCM
Usage:
Isotype:Mouse IgG2a, κ
Clonality:Monoclonal
Clone NO.:LL2
UNIProt ID:P20273
Background:Siglecs (sialic acid binding Ig-like lectins) are I-type (Ig-type) lectins belonging to the Ig superfamily. They are characterized by an N-terminal Ig-like V-type domain which mediates sialic acid binding, followed by varying numbers of Ig-like C2-type domains. Human Siglec-2, also known as B-cell antigen CD22 or Blymphocyte cell adhesion molecule (BL-CAM), is a B-cell restricted glycoprotein that is expressed in the cytoplasm of progenitor B and pre-B cells and on the surface of mature B cells. Two distinct human Siglec2/CD22 cDNAs that arise from differential RNA processing of the same gene have been isolated. Siglec2/CD22 is an adhesion molecule that preferentially binds alpha 2,6- linked sialic acid on the same (cis) or adjacent (trans) cells. Interaction of CD22 with trans ligands on opposing cells was found to be favored over the binding of ligands in cis.
Concentration:≥ 1 mg/mL
Control catalog number:
Immunogen:Recombinant Human CD22 protein
Buffer:Phosphate-buffered solution, pH 7.2, containing 0.05% non-protein stabilizer. Dialyze to completely remove the stabilizer prior to labeling.
Purification method:>98%, Protein A/G purified
Dilution:FCM 2 μg/mL(0.5×106-1×106 cells)
GeneID:933
![Purified Anti-Human CD22 Antibody[LL2]](http://www.genebiosystems.com/cdn/shop/files/no_image_default_image-jpeg_6016a3c9-4ee8-4bcb-bedc-5b46483e1170.jpg?v=1782788023&width=1445)